Open AccessCan we change autoimmunity in Type 1 Diabetes via insulin injection or oral insulin?
Author(s) -
Muyun Cao
Publication year - 2019
Publication title -
journal of medical research and innovation
Language(s) - English
Resource type - Journals
ISSN - 2456-8139
DOI - 10.32892/jmri.196
Subject(s) - proinsulin , autoimmunity , insulin , medicine , type 1 diabetes , diabetes mellitus , type 2 diabetes , immune system , autoimmune disease , disease , immunology , endocrinology
This article reviews recent immunotherapy studies of Type 1 Diabetes (T1D) which is an autoimmune disease. Researchers show that injecting human proinsulin peptides can safely modulate the immune system and affect beta-cell function in Type 1 Diabetes, but oral insulin consumption does not reduce the onset of Type 1 Diabetes in individuals at the early stage of the disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom